AtriCure Inc. | Key People and Executives
Michael H. Carrel
President, Chief Executive Officer & Director
Scott William Drake
Chairman
B. Kristine Johnson
Independent Director
Regina Groves
Independent Director
Sven A. Wehrwein
Independent Director
Mark R. Lanning
Independent Director
Mark A. Collar
Independent Director
Robert S. White
Independent Director
Michael H. Carrel
President, Chief Executive Officer & Director
Douglas J. Seith
Chief Operating Officer
M. Andrew Wade
CFO, Principal Accounting Officer & Senior VP
Salvatore Privitera
Chief Technology Officer
Vini Doraiswamy
SVP-Clinical, Regulatory & Scientific Affairs
David Francischelli
Vice President-Research & Development
Andrew L. Lux
Senior VP-Operations & Quality Assurance
Karl Dahlquist
Chief Compliance Officer, VP-Legal & Regulatory
Michael J. Rogge
VP-Professional Education & Scientific Affairs
Justin J. Noznesky
Senior VP-Marketing & Business Development
Tonya Austin
Vice President-Human Resources
Scott William Drake
Chairman
B. Kristine Johnson
Independent Director
Regina Groves
Independent Director
Sven A. Wehrwein
Independent Director
Mark R. Lanning
Independent Director
Mark A. Collar
Independent Director
Robert S. White
Independent Director
| Address |
7555 Innovation Way
Mason Ohio 45069
United States
|
|
Employees
|
- |
| Website |
http://www.atricure.com |
| Updated |
07/08/2019 |
| AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures. |
